111 related articles for article (PubMed ID: 20048171)
61. [p53 as a biomarker in radiotherapy of carcinoma of the mouth cavity].
Girod SC; Kaupe M; Pfeiffer P; Pape HD
Mund Kiefer Gesichtschir; 1998 Jan; 2(1):11-3. PubMed ID: 9522566
[TBL] [Abstract][Full Text] [Related]
62. Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to Neo-Adjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis.
Thiagarajan S; Dhar H; Bhattacharjee A; Fatehi KS; Shah SB; Chaukar D; Nair D; Deshmukh A; Prabhash K; Joshi A; Patil V; Noronha V; Laskar SG; Cruz AKD
Oral Oncol; 2020 Jan; 100():104455. PubMed ID: 31739192
[No Abstract] [Full Text] [Related]
63. Chemotherapy for Oral Cancer.
Hartner L
Dent Clin North Am; 2018 Jan; 62(1):87-97. PubMed ID: 29126496
[TBL] [Abstract][Full Text] [Related]
64. Clinical response to fluorouracil and p53.
Augenlicht LH; Wadler S; Arango D
N Engl J Med; 2001 Oct; 345(14):1065-6. PubMed ID: 11586966
[No Abstract] [Full Text] [Related]
65. Spindle Cell Carcinoma of the Oral Cavity: the Impact of Chemotherapy on Pulmonary Metastatic Tumor Doubling Time.
Shigeta T; Minamikawa T; Matsui T; Kakei Y; Akashi M; Hasegawa T; Sakakibara A; Shibuya Y; Komori T
Kobe J Med Sci; 2015 Dec; 61(3):E64-70. PubMed ID: 27323785
[TBL] [Abstract][Full Text] [Related]
66. Reply to K. Devisetty et al.
Zhong LP; Zhang ZY
J Clin Oncol; 2013 Aug; 31(23):2972-3. PubMed ID: 24079021
[No Abstract] [Full Text] [Related]
67. p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity.
Tavassoli M; Brunel N; Maher R; Johnson NW; Soussi T
Int J Cancer; 1998 Oct; 78(3):390-1. PubMed ID: 9766578
[No Abstract] [Full Text] [Related]
68. Surgical site infection after preoperative neoadjuvant chemotherapy in patients with locally advanced oral squamous cell carcinoma.
Liu SA; Wong YK; Wang CP; Wang CC; Jiang RS; Ho HC; Lin JC
Head Neck; 2011 Jul; 33(7):954-8. PubMed ID: 21674671
[TBL] [Abstract][Full Text] [Related]
69. Quantitative analysis of nuclear shape in oral squamous cell carcinoma is useful for predicting the chemotherapeutic response.
Ogura M; Yamamoto Y; Miyashita H; Kumamoto H; Fukumoto M
Med Mol Morphol; 2016 Jun; 49(2):76-82. PubMed ID: 26439725
[TBL] [Abstract][Full Text] [Related]
70. Neoadjuvant chemotherapy for unresectable oral cancers: Optimizing outcomes?
Puri T
Indian J Cancer; 2017; 54(2):394-396. PubMed ID: 29469065
[No Abstract] [Full Text] [Related]
71. Cisplatin based adjuvant chemoradiation following neoadjuvant chemotherapy and surgery in advanced oral cavity cancers: A deliverable regimen?
Noronha V; Joshi A; Patil V; Dhumal S; Agarwal JP; Ghosh-Lashkar S; Prabhash K
Indian J Cancer; 2016; 53(1):141-2. PubMed ID: 27146765
[No Abstract] [Full Text] [Related]
72. Use of a trypsin, Peru balsam, and castor oil spray on the oral mucosa: case report and review of the literature.
Noble TA; Carr DS; Gonzalez MF
Pharmacotherapy; 1989; 9(6):386-8. PubMed ID: 2694114
[TBL] [Abstract][Full Text] [Related]
73. SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than
Fujihara KM; Corrales Benitez M; Cabalag CS; Zhang BZ; Ko HS; Liu DS; Simpson KJ; Haupt Y; Lipton L; Haupt S; Phillips WA; Clemons NJ
Mol Cancer Ther; 2021 Oct; 20(10):1858-1867. PubMed ID: 34315763
[TBL] [Abstract][Full Text] [Related]
74. Oral and maxillofacial surgeons treating oral cancer: a preliminary report from the American Association of Oral and Maxillofacial Surgeons Task Force on Oral Cancer.
Kademani D; Bell RB; Schmidt BL; Blanchaert R; Fernandes R; Lambert P; Tucker WM;
J Oral Maxillofac Surg; 2008 Oct; 66(10):2151-7. PubMed ID: 18848117
[No Abstract] [Full Text] [Related]
75. Cancer of the oral cavity.
Chen AY; Myers JN
Curr Probl Surg; 2000 Oct; 37(10):633-731. PubMed ID: 11055204
[No Abstract] [Full Text] [Related]
76. Influence of cisplatinum and 5-fluorouracil on the oral mucosa.
Zöller J; Flentje M; Born IA; Osswald H
Eur J Cancer B Oral Oncol; 1994 May; 30B(3):200-3. PubMed ID: 7920167
[TBL] [Abstract][Full Text] [Related]
77. Time to revisit the tumor margins in post NACT oral squamous cell carcinoma.
Joshna BM; Subash A; Thakur S; Rao V
Oral Oncol; 2020 Oct; 109():104679. PubMed ID: 32265104
[No Abstract] [Full Text] [Related]
78. Management of oral squamous cell carcinoma in situ with topical 5-fluorouracil and laser surgery.
Maxson BB; Scott RF; Headington JT
Oral Surg Oral Med Oral Pathol; 1989 Jul; 68(1):44-8. PubMed ID: 2666897
[TBL] [Abstract][Full Text] [Related]
79. Current management of oral cancer. A multidisciplinary approach.
Ord RA; Blanchaert RH
J Am Dent Assoc; 2001 Nov; 132 Suppl():19S-23S. PubMed ID: 11803648
[TBL] [Abstract][Full Text] [Related]
80. Context-dependent therapeutic potential of FOXO proteins in oral squamous cell carcinoma.
Link W
Oral Oncol; 2011 Apr; 47(4):229-30. PubMed ID: 21376658
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
